Stay updated with breaking news from Non Invasive Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cash, cash equivalents and current financial assets totaled €111.8 million as of June 30, 2023 Positive results in the pivotal Phase 3 ELATIVE® trial in June 2023, paving the way to: a potential submission to the
Cash, cash equivalents and current financial assets totaled €111.8 million as of June 30, 2023 Positive results in the pivotal Phase 3 ELATIVE® trial in...
Lille ; Cambridge ; Zurich ; August 10, 2023 - GENFIT , a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and severe liver diseases, today announced the... -Today at 04:11 pm- MarketScreener
Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); August 10, 2023 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients
/PRNewswire/ -- Allied Market Research published a report, titled, "Helicobacter Pylori Diagnostics Market by Test Type (Non-Invasive Test, and Invasive Test),...